Close X
Attorney Spotlight

After finishing her first year as an associate at Bass, Berry & Sims, find out what advice Margaret Dodson offers to new attorneys. Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Blueprint for an IPO

Companies go public to raise capital to fuel growth, pay down debt and provide liquidity to shareholders. Although all issuers and offerings are different, the basic process of going public remains relatively constant. Blueprint for an IPO identifies the key players, details the process and identifies the obligations companies will face after going public.

Read now

Quorum Spinoff Named Corporate & Strategic Deal of the Year (over $500MM) by The M&A Advisor

November 14, 2016

Nashville, Tenn., (November 14, 2016) - Bass, Berry & Sims was recognized by The M&A Advisor for our work on behalf of Community Health Systems in the spinoff of Quorum Health Corporation and disposition of 38 hospitals. The transaction was named the "Corporate & Strategic Deal of the Year (over $500MM)" at the 2016 M&A Advisor Awards 15th Annual Gala held on November 9, 2016, in New York City.

Bass, Berry & Sims served on the team that completed this transaction in April 2016 that resulted in the independent, public-company formation of Quorum (NYSE: QHC) that owns or leases a portfolio of 38 hospitals across 16 states. The spin-off was the first public-public spin-off by a hospital company in more than 15 years and the first to occur in the contemporary healthcare regulatory environment.

The M&A Advisor reported that this year, more than 320 nominees, representing over 615 companies, became finalists for the awards. An independent judging committee of 35 top M&A industry experts determined the ultimate recipients of the awards.

About The M&A Advisor
The M&A Advisor was founded in 1998 to offer insights and intelligence on M&A activities. Over the past 18 years the firm has established the premier global network of M&A, Turnaround and Finance professionals. Today, The M&A Advisor has the privilege of presenting, recognizing the achievements of, and facilitating connections between the industry's top performers throughout the world with a comprehensive range of services. To learn more visit www.maadvisor.com.

About Bass, Berry & Sims PLC
With more than 260 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims has been involved in some of the largest and most significant litigation matters and business transactions in the country. For more information, visit www.bassberry.com.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.